e-learning
resources
Vienna 2003
Monday 29.09.2003
"Asthma: inhaled therapy; allergic bronchopulmonary aspergillosis"
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The relevance of the delivery system to the efficacy of the association beta2 agonists/steroids in asthma
R. Pistelli, F. Baldari, S. Sammarro (Rome, Italy)
Source:
Annual Congress 2003 - Asthma: inhaled therapy; allergic bronchopulmonary aspergillosis
Session:
"Asthma: inhaled therapy; allergic bronchopulmonary aspergillosis"
Session type:
Thematic Poster Session
Number:
1577
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Pistelli, F. Baldari, S. Sammarro (Rome, Italy). The relevance of the delivery system to the efficacy of the association beta2 agonists/steroids in asthma. Eur Respir J 2003; 22: Suppl. 45, 1577
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Variability and lack of predictive ability of asthma end-points in clinical trials
Source: Eur Respir J 2002; 20: 1102-1109
Year: 2002
Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?
Source: Eur Respir J 2004; 24: 1-2
Year: 2004
Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
A comparative study to evaluate the effects of salmetrol/fluticasone and formoterol/budesonide combinations on lung functions and sleep quality in asthma
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021
Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009
Asthma management - The role of drug delivery
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
A novel asthma monitoring system for asthma management in children
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005
Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
The ability of fluctuation analysis of airway function and symptoms to asses asthma stability in different asthma phenotypes
Source: Eur Respir J 2007; 30: Suppl. 51, 257s
Year: 2007
Effectiveness
versus
efficacy trials in COPD: how study design influences outcomes and applicability
Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017
Year: 2018
Ease of use of inhalers and its impact on treatment adherence and control of asthma. An observational study
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Methacoline challenge response in controlled asthma and correlations with other disease characteristics
Source: Annual Congress 2012 - Asthma management
Year: 2012
An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD
Source: Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018
Year: 2018
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma
Source: Eur Respir J 2006; 28: 1042-1050
Year: 2006
Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006
The impact of different asthma phenotypes on the outcome
Source: Annual Congress 2012 - Asthma from childhood to adulthood: what factors predict the outcome?
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept